Fund Holdings — Rosalind Advisors, Inc.

Total Portfolio Value:
$205.23M
Total Bought:
$58.55M
Total Sold:
$31.16M
Net Transaction:
+$27.39M
Securities
▲▼
SharesValue
Q4 2024
▲▼
Q1 2025
▲▼
Change
▲▼
Q4 2024
▲▼
Q1 2025
▲▼
Weight (%)
▲▼
Change
▲▼
Delcath Systems, Inc.(DCTH)2,650,3892,900,389+250,000$31.91M$29.00M14.13%-$2.91M
Verastem, Inc.(VSTM)900,0002,644,517+1,744,517$4.65M$15.95M7.77%+$11.29M
Xeris Biopharma Holdings Inc3,104,9952,495,986-609,009$10.53M$13.70M6.68%+$3.18M
Myomo, Inc.(MYO)2,998,9452,703,661-295,284$19.31M$13.00M6.34%-$6.31M
IDEAYA Biosciences, Inc.(IDYA)0700,000+700,000$0$11.47M5.59%+$11.47M
Fennec Pharmaceuticals Inc.(FENC)1,259,8761,782,844+522,968$7.96M$10.86M5.29%+$2.90M
UroGen Pharma Ltd.(URGN)870,000950,000+80,000$9.27M$10.51M5.12%+$1.24M
Ocular Therapeutix, Inc.(OCUL)1,128,7001,218,700+90,000$9.64M$8.93M4.35%-$706.0K
Abeona Therapeutics Inc.(ABEO)1,805,3901,805,817+427$10.06M$8.60M4.19%-$1.46M
Replimune Group, Inc.(REPL)260,000850,000+590,000$3.15M$8.29M4.04%+$5.14M
Viridian Therapeutics, Inc.(VRDN)0595,000+595,000$0$8.02M3.91%+$8.02M
MediWound Ltd.SHS NEW(MDWD)628,050506,893-121,157$11.18M$7.87M3.83%-$3.31M
Savara Inc.(SVRA)2,654,9442,654,9440$8.15M$7.35M3.58%-$796.5K
Verona Pharma PlcADS150,000100,000-50,000$6.97M$6.35M3.09%-$617.0K
InspireMD, Inc.(NSPR)2,495,7832,274,990-220,793$6.56M$6.12M2.98%-$444.2K
Helus Pharma Inc(HELP)810,918810,9180$7.15M$5.14M2.51%-$2.01M
Nuvation Bio Inc.CL A(NUVB)02,451,500+2,451,500$0$4.31M2.10%+$4.31M
Profound Medical Corp.(PROF)692,185692,1850$5.20M$4.03M1.96%-$1.17M
Trevi Therapeutics, Inc.(TRVI)1,062,500612,901-449,599$4.38M$3.86M1.88%-$522.4K
Pharvaris N V
COM
0223,627+223,627$0$3.51M1.71%+$3.51M
Kalvista Pharmaceuticals Inc303,864303,8640$2.57M$3.51M1.71%+$932.9K
PolyPid Ltd.(PYPD)1,018,0211,018,0210$3.09M$2.76M1.34%-$335.9K
Mind Medicine Mindmed Inc0420,000+420,000$0$2.46M1.20%+$2.46M
COMPASS Pathways plcADS(CMPS)707,625823,286+115,661$2.67M$2.35M1.15%-$320.2K
Optinose Inc876,996256,190-620,806$5.86M$2.35M1.14%-$3.51M
Cogent Biosciences, Inc.(COGT)0248,285+248,285$0$1.49M0.72%+$1.49M
Talphera, Inc.(TLPH)613,9392,003,939+1,390,000$321.8K$992.0K0.48%+$670.2K
Kiora Pharmaceuticals, Inc.(KPRX)250,555250,059-496$826.8K$752.7K0.37%-$74.2K
Kura Oncology, Inc.(KURA)0100,000+100,000$0$660.0K0.32%+$660.0K
Alpha Cognition Inc. Common Stock(ACOG)252,753104,836-147,917$1.49M$530.5K0.26%-$958.2K
Biofrontera Inc.(BFRI)811,918644,393-167,525$885.0K$515.5K0.25%-$369.5K
Filana Therapeutics, Inc.(FLNA)417,4000-417,400$985.1K$0—-$985.1K
Chimerix Inc3,050,0000-3,050,000$10.61M$0—-$10.61M
Owlet, Inc.CL A(OWLT)49,4410-49,441$220.0K$0—-$220.0K
Relmada Therapeutics, Inc.(RLMD)100,0000-100,000$52.0K$0—-$52.0K
Page 1 of 1
Rosalind Advisors, Inc. — 13F Holdings — Q1 2025 | TickerTrail